JP2011251952A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011251952A5 JP2011251952A5 JP2010128203A JP2010128203A JP2011251952A5 JP 2011251952 A5 JP2011251952 A5 JP 2011251952A5 JP 2010128203 A JP2010128203 A JP 2010128203A JP 2010128203 A JP2010128203 A JP 2010128203A JP 2011251952 A5 JP2011251952 A5 JP 2011251952A5
- Authority
- JP
- Japan
- Prior art keywords
- hypoglycemic
- substance
- chitinase3
- like4
- searching
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000126 substance Substances 0.000 claims 16
- 230000002218 hypoglycaemic effect Effects 0.000 claims 13
- 241000255789 Bombyx mori Species 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- 210000001124 body fluid Anatomy 0.000 claims 5
- 239000003472 antidiabetic agent Substances 0.000 claims 4
- 238000011156 evaluation Methods 0.000 claims 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 4
- 102100038196 Chitinase-3-like protein 1 Human genes 0.000 claims 3
- 101000883515 Homo sapiens Chitinase-3-like protein 1 Proteins 0.000 claims 3
- 239000008280 blood Substances 0.000 claims 3
- 210000004369 blood Anatomy 0.000 claims 3
- 239000010839 body fluid Substances 0.000 claims 3
- 229940126904 hypoglycaemic agent Drugs 0.000 claims 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 2
- 102000004877 Insulin Human genes 0.000 claims 2
- 108090001061 Insulin Proteins 0.000 claims 2
- 241001465754 Metazoa Species 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 239000008103 glucose Substances 0.000 claims 2
- 229940125396 insulin Drugs 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000002243 precursor Substances 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102100037839 Acidic mammalian chitinase Human genes 0.000 claims 1
- 102100037328 Chitotriosidase-1 Human genes 0.000 claims 1
- 101000738085 Homo sapiens Acidic mammalian chitinase Proteins 0.000 claims 1
- 229940125708 antidiabetic agent Drugs 0.000 claims 1
- 108010057052 chitotriosidase Proteins 0.000 claims 1
- 230000007423 decrease Effects 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 235000013376 functional food Nutrition 0.000 claims 1
- 229930182830 galactose Natural products 0.000 claims 1
- 230000010030 glucose lowering effect Effects 0.000 claims 1
- 230000003345 hyperglycaemic effect Effects 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010128203A JP5710157B2 (ja) | 2010-06-03 | 2010-06-03 | 血糖降下物質 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010128203A JP5710157B2 (ja) | 2010-06-03 | 2010-06-03 | 血糖降下物質 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011251952A JP2011251952A (ja) | 2011-12-15 |
| JP2011251952A5 true JP2011251952A5 (enExample) | 2014-04-17 |
| JP5710157B2 JP5710157B2 (ja) | 2015-04-30 |
Family
ID=45416209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010128203A Active JP5710157B2 (ja) | 2010-06-03 | 2010-06-03 | 血糖降下物質 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5710157B2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6388786B2 (ja) * | 2014-04-24 | 2018-09-12 | 株式会社ゲノム創薬研究所 | 高血糖カイコを用いた2型糖尿病に対する予防・治療薬の評価方法、スクリーニング方法、及び、製造方法 |
| CN104262463B (zh) * | 2014-09-28 | 2016-11-30 | 青岛橡胶谷知识产权有限公司 | 蚕蛹多肽及其制备方法、应用 |
| CN104311632A (zh) * | 2014-09-28 | 2015-01-28 | 苏州普罗达生物科技有限公司 | 一种蚕蛹多肽及其制备方法、应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040087514A1 (en) * | 2002-09-06 | 2004-05-06 | Hughes Thomas E | Nutritional compositions |
| JP5897796B2 (ja) * | 2008-07-08 | 2016-03-30 | 株式会社ゲノム創薬研究所 | 血糖低下剤及びそれを添加してなる糖尿病の予防又は症状改善のための飲食品 |
-
2010
- 2010-06-03 JP JP2010128203A patent/JP5710157B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fontana et al. | New acetogenin peroxides from the Indian sponge Acarnus bicladotylota | |
| Mañas-García et al. | Satellite cells and markers of muscle regeneration during unloading and reloading: Effects of treatment with resveratrol and curcumin | |
| Aronov et al. | Retinal vascular signs as screening and prognostic factors for chronic kidney disease: a systematic review and meta-analysis of current evidence | |
| JP2011251952A5 (enExample) | ||
| Alicic et al. | Incretin therapies for patients with type 2 diabetes and chronic kidney disease | |
| Fiorentino et al. | Frequency of 1-h post-load glucose≥ 155 mg/dl among individuals with different glucose tolerance conditions | |
| CN104262463B (zh) | 蚕蛹多肽及其制备方法、应用 | |
| Demir et al. | Effect of hepatitis C virus infection on the left ventricular systolic and diastolic functions. | |
| Tellez et al. | Metabolic outcomes in pediatric patients one-year post-total pancreatectomy with islet autotransplantation after early pump initiation | |
| Shen | Preliminary discussion on the prevention and treatment of shock after severe burns | |
| Snigur et al. | Structural alterations in pancreatic islets in streptozotocin-induced diabetic rats treated with of bioactive additive on the basis of Gymnema sylvestre | |
| Khurana et al. | Orthostatic hypotension in kidney pancreas transplant patients and its relation to preexisting autonomic neuropathy. | |
| 曾德朋 et al. | Autologous serum skin test and autologous whole blood injections to patients with chronic urticaria: A retrospective analysis | |
| Kostek et al. | Is it possible to survive metabolic acidosis with pH measure below 6.8? A study of two cases of inedible alcohol intoxication | |
| Guan et al. | Elimination half-life of propofol in effect-site of mice | |
| Bojić et al. | The effect of gender on vasomotor function of the vascular endothelium and cardiovascular remodelling during aging | |
| Chahal et al. | Takotsubo cardiomyopathy: case report and review of the literature. | |
| Vázquez-Antona et al. | Left ventricular outflow tract obstruction in transposition of the great arteries. Correlation between anatomic and echocardiographic findings | |
| LUO et al. | Relationship between serum concentration of uric acid and the severity of coronary artery disease | |
| Lu et al. | Effects of acute hypervolemic hemodilution with hydroxyethyl starch 130/0.4 on the lung in a rabbit model of sepsis | |
| Rodriguez et al. | Analysis of the clinical course of patients with type 2 diabetes mellitus from onset of insulin treatment (EDIN study): baseline characteristics of patients | |
| Nelaj et al. | Prevalence of diabetic retinopathy and its relation with other risk factors | |
| Bernal-Rodríguez et al. | Intracranial venous thrombosis: reports on 11 paediatric cases | |
| Serwin et al. | Inflammation focal spots in uncontrolled diabetes | |
| Bagci et al. | The effect of CCR2 G190A gene polymorphism on development of diabetic coronary artery disese |